Diagnos Laboratorium Utama Tbk. vs Bank Nationalnobu Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while Bank Nationalnobu Tbk. trades at Rp436 (market cap 3.14T, 524.4K 24h volume). The key difference: Bank Nationalnobu Tbk. is far larger — about 10.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Bank Nationalnobu Tbk. is more actively traded (524.4K versus 27.5K). Which is the better fit depends on your goals.
| DGNS | NOBU | |
|---|---|---|
Market Cap | 308B | 3.14T |
Volume | 27.5K | 524.4K |
Lot | 275 | 5.24K |
Turnover | 6.23M | 226.4M |
Average Price | 226.59 | 431.73 |
Value | 6.23M | 226.4M |
Indicative Equilibrium Price | 230 | 424 |
Indicative Equilibrium Volume | 110 | 800 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Bank Nationalnobu Tbk (formerly PT Bank Alfindo) was established in Jakarta on February 13, 1990 based on the Notarial Deed No. 86 from Drs. Entjoen Mansoer Wiriatmadja, S.H., a notary in Jakarta.
Read more on NOBU →